Related Experiment Video
Updated: Jun 19, 2026

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
THE PRESENCE OF PROTECTIVE SUBSTANCES IN HUMAN SERUM DURING LOBAR PNEUMONIA
1Hospital of The Rockefeller Institute for Medical Research, New York.
Abstract:
These experiments demonstrate that protective substances are usually present in the blood of patients recovering from lobar pneumonia. As a rule, the appearance of protective bodies in the blood, when demonstrable, coincides rather sharply with the period of critical fall in temperature and the disappearance of symptoms. These substances are not present in the blood in any measurable degree before the crisis, but afterward they may reach a considerable concentration. In certain instances, protective substances either become evident some time after the occurrence of the crisis, or cannot be demonstrated at any period of the disease. Experiments in which it is possible to test serum against an homologous strain of pneumococcus yield in the majority of cases evidence of the presence of protective bodies; whereas in those in which stock cultures are used, the serum, as a rule, shows no protection. The development of specific protective substances in the serum of patients with lobar pneumonia suggests that these bodies may play a part in the mechanism of recovery.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Atypical Pneumonia
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

